Discover
AUTL
Autolus Therapeutics plc
1.58
2 x 1.15
2 x 1.99
bid
ask
-
0.02
1.25%
2 @ 04:52 AM
1.62 +0.04 (2.72%)
| Ytd | -20.60% | |
| 1y | -31.00% |
1.55
day range
1.63
1.18
52 week range
2.70
| Open | 1.60 | Prev Close | 1.60 | Low | 1.55 | High | 1.63 | Mkt Cap | 420.51M |
| Vol | 685.06K | Avg Vol | 1.39M | EPS | -1.09 | P/E | N/A | Forward P/E | -3.08 |
| Beta | 2.04 | Short Ratio | 2.48 | Inst. Own | 77.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 1.59 | 200-d Avg | 1.54 | 1yr Est | 10.45 |
AUTL News
globenewswire.com
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LONDON & GAITHERSBURG, Md., July 01, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL
globenewswire.com
Autolus Therapeutics to Participate in Upcoming Investor Conference
LONDON and GAITHERSBURG, Md., June 25, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AU